ZS/DC_P-011

N/A

Report date: 2022/09/13 16:54:27

Base Information

Drug NameZS/DC_P-011

Drug Alias NameZS/DC_P-011

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsBiliary Tract Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesZhongsheng Kangyuan Biotechnology (Beijing) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesZhongsheng Kangyuan Biotechnology (Beijing) Co Ltd

Inactive CompaniesN/A

Active IndicationsBiliary Tract Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A